Analysis of data collected in the European Society for Blood and Marrow Transplantation (EBMT) Registry on a cohort of lymphoma patients receiving plerixafor
-
Sureda, Anna (Institut Català d'Oncologia)
;
Chabannon, Christian (Institut Paoli-Calmettes) ;
Masszi, Tamás (Semmelweis University) ;
Pohlreich, David (Charles University Hospital) ;
Scheid, Christof (University of Cologne) ;
Thieblemont, Catherine (Hôpital Saint-Louis) ;
Wahlin, Björn E. (Karolinska University Hospital and Karolinska Institutet (Suecia)) ;
Sakellari, Ioanna (George Papanicolaou General Hospital (Tessalònica, Grècia)) ;
Russell, Nigel (Nottingham University Hospital) ;
Janikova, Andrea (University Hospital Brno (República Txeca)) ;
Dabrowska-Iwanicka, Anna (Maria Sklodowska-Curie Institute-Oncology Center) ;
Touzeau, Cyrille (CHU Nantes) ;
Esquirol, Albert (Institut d'Investigació Biomèdica Sant Pau) ;
Jantunen, Esa (University of Eastern Finland and Kuopio University Hospital) ;
van der Werf, Steffie (EBMT Data Office) ;
Bosman, Paul (EBMT Data Office) ;
Boumendil, Ariane (EBMT Statistical Unit) ;
Liu, Qianying (Sanofi Genzyme) ;
Celanovic, Marina (Sanofi Genzyme) ;
Montoto, Silvia (St Bartholomew's Hospital) ;
Dreger, Peter (University of Heidelberg) ;
Universitat Autònoma de Barcelona
visitant ::
identificació
Subscriure's to this discussion. You will then receive all new comments by email.
